← All stocks

Bolt Biotherapeutics, Inc.

BOLT Net selling
CIK 0001641281 #5380 in the set updated 22 Sep 2026
Bought (12 mo)
$5.59K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$128.28K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$128.28K
9 of 9 sales
Net
−$122.69K
−$122.69K against sales at will

By person

3 insiders · 13 transactions
0.1×

William P. Quinn holds only 0.1 times base salary in stock. $82.15K of shares against $463.50K in salary for 2025.

Salary from the company's own proxy. The shares are what William P. Quinn last reported holding, valued at $3.24, the price Common Stock was last bought or sold at on the open market here, on 18 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Quinn William P.
President, CEO and CFO
$3.04K (2)
$58.40K (3)
−$55.36K
25,384
$82.15K
Yonehiro Grant
Chief Operating Officer
$43.81K (3)
−$43.81K
17,269
$55.89K
+3,781%
Nemec Sarah
Senior VP, Finance and PAO
$2.55K (2)
$26.07K (3)
−$23.52K
17,082
$55.28K

No percentages here. This company's share count has moved by a factor of 20.0 over the window, from 1,919,441 to 38,339,697 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Quinn William P.
5 Jun 2026
President, CEO and CFO
Buy
637
$3.88
$2.47K
Nemec Sarah
5 Jun 2026
Senior VP, Finance and PAO
Buy
509
$3.88
$1.97K
Nemec Sarah
5 Dec 2025
Senior VP, Finance and PAO
Buy
125
$4.61
$575.88
Quinn William P.
5 Dec 2025
President, CEO and CFO
Buy
125
$4.61
$575.88

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 93,000
History held since 8 Feb 2021